 Now, I'm sure you're sick of talking about Ozempic and the company that makes it, Novo Nordisk. But interestingly, its share price actually went down after a study found that its rival, Eli Lilly, makes more effective diabetes and weight loss drugs. But it's likely only a bump in the road for Novo, which has become one of the largest pharma companies in the world by market cap.